Ca Atra
Ca Atra (All-trans Retinoic Acid 10 mg) — Cipla differentiating agent for acute promyelocytic leukaemia (APL). Combined with anthracycline or arsenic trioxide for near-curative response.
✓ Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience · Last reviewed: May 2026
Quick Answer
Ca Atra — All-trans Retinoic Acid (Tretinoin) 10 mg (Cipla Inc). Differentiating agent for acute promyelocytic leukaemia (APL) — combined with anthracycline or arsenic trioxide gives near-curative remission rates. Specialist haematology supervision.
What you get with MedsBase:
- WHO-GMP certified manufacturer
- Discreet plain-envelope packaging
- Worldwide shipping
- Rated by 1,400+ customers (read reviews)
📦 Reshipment Assurance: if your order has not arrived 20 business days after dispatch, we reship it at no extra cost. Read the policy.
Why order from MedsBase
Ca Atra ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.
⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.
Differentiation syndrome (formerly retinoic acid syndrome) — fever, dyspnoea, weight gain, peripheral oedema, hypotension, pleural/pericardial effusion. Occurs days 5-21 of induction. Treat immediately with high-dose dexamethasone. Mortality rate ~10% if unrecognised. Mandatory haematology monitoring.
Frequently Asked Questions
When is this used?
Differentiating agent for acute promyelocytic leukaemia (APL) — combined with anthracycline or arsenic trioxide gives near-curative remission rates. Specialist haematology supervision. Specific protocols are oncologist-determined.
Side effects?
Class-typical: myelosuppression, nausea, alopecia, mucositis, fatigue. Specific toxicities depend on the drug — see safety boxes above.
Drug interactions?
Cancer chemotherapy has multiple critical interactions. Always disclose all medications including herbals and supplements. Anticoagulants, anticonvulsants, antibiotics, antifungals, and antivirals all need review.
Pregnancy?
Cytotoxic chemotherapy is teratogenic. Effective contraception during and for 6 months after for both partners.
Monitoring?
Specialist-determined — typically FBC, renal/liver function, electrolytes before each cycle. Drug-specific tests (echocardiogram for anthracyclines, audiometry for cisplatin, etc.).
What if I miss a dose?
Oral cytotoxics: skip the missed dose, do not double up, contact your oncology team. IV: dosing is strictly scheduled — discuss any delay or missed cycle with the specialist.
Storage?
Oral cytotoxics: at room temperature, away from children, in original blister. Hand washing after handling tablets. Pregnant household members should not handle broken tablets.
Vaccines?
Live vaccines are contraindicated during chemotherapy. Inactivated vaccines (annual influenza, pneumococcal) are recommended. Coordinate with oncology for timing.
Long-term complications?
Class-dependent: secondary malignancy, infertility, cardiotoxicity, neuropathy. Discuss with oncology — fertility preservation may be relevant before starting.
When is treatment finished?
Determined by tumour response, treatment intent (curative vs palliative), and toxicity. Imaging and clinical assessment guide ongoing therapy.
Other Cancer Medications
- Xeloda — capecitabine 500 mg — oral 5-FU prodrug for breast/colorectal/gastric cancers
- Altraz — anastrozole 1 mg — aromatase inhibitor for post-menopausal breast cancer
- Xbira — abiraterone 250 mg — CYP17 inhibitor for metastatic prostate cancer
- Zoldria — zoledronic acid IV — for bone metastases and hypercalcaemia
- Actorise — darbepoetin alfa — for chemotherapy-induced anaemia
More options in Anti Cancer Medication
Ranked by recent MedsBase order volume — what other customers in this category are picking.
| Strength | 10 mg |
|---|---|
| Quantity | 100 Capsule/s, 200 Capsule/s, 300 Capsule/s |
| Pharma Form | Soft Gelatin Capsules |
| Manufacturer | Jenome Biophar |
| Treatment | Acute promyelocytic leukemia |
| Generic Brand | Tretinoin (All-trans Retinoic Acid) |
Ca Atra
Q & A
Ca Atra
Related products
Reviews
There are no reviews yet